Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124178134 | 12417813 | 4 | F | 20160420 | 20160708 | 20160530 | 20160715 | EXP | US-KADMON PHARMACEUTICALS, LLC-KAD201605-001937 | KADMON | 55.29 | YR | F | Y | 60.77000 | KG | 20160715 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124178134 | 12417813 | 1 | PS | RIBASPHERE | RIBAVIRIN | 1 | Oral | 200 MG THREE CAPSULES IN THE MORNING AND TWO IN THE EVENING; DAILY DOSE: 1000 MG | 76203 | 200 | MG | ||||||||
| 124178134 | 12417813 | 2 | SS | SOVALDI | SOFOSBUVIR | 1 | Oral | 0 | 400 | MG | |||||||||
| 124178134 | 12417813 | 3 | C | LACTULOSE. | LACTULOSE | 1 | Oral | 0 | |||||||||||
| 124178134 | 12417813 | 4 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0 | 100 | UG | ||||||||||
| 124178134 | 12417813 | 5 | C | Lisinopril+HCTZ | 2 | 0 | |||||||||||||
| 124178134 | 12417813 | 6 | C | NICODERM CQ | NICOTINE | 1 | 0 | ||||||||||||
| 124178134 | 12417813 | 7 | C | Plaquanil | 2 | 0 | 200 | MG | |||||||||||
| 124178134 | 12417813 | 8 | C | GABAPENTIN. | GABAPENTIN | 1 | 0 | ||||||||||||
| 124178134 | 12417813 | 9 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | 0 | 40 | MG | ||||||||||
| 124178134 | 12417813 | 10 | C | PROMETHAZINE | PROMETHAZINEPROMETHAZINE HYDROCHLORIDE | 1 | 0 | 25 | MG | ||||||||||
| 124178134 | 12417813 | 11 | C | PROMETHAZINE | PROMETHAZINEPROMETHAZINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 124178134 | 12417813 | 12 | C | PROVERA | MEDROXYPROGESTERONE ACETATE | 1 | 0 | 2.5 | MG | ||||||||||
| 124178134 | 12417813 | 13 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 124178134 | 12417813 | 14 | C | ESTRADIOL. | ESTRADIOL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124178134 | 12417813 | 1 | Hepatitis C |
| 124178134 | 12417813 | 2 | Hepatitis C |
| 124178134 | 12417813 | 3 | Constipation |
| 124178134 | 12417813 | 4 | Hypothyroidism |
| 124178134 | 12417813 | 5 | Hypertension |
| 124178134 | 12417813 | 6 | Nicotine dependence |
| 124178134 | 12417813 | 7 | Osteoarthritis |
| 124178134 | 12417813 | 8 | Arthralgia |
| 124178134 | 12417813 | 9 | Gastrooesophageal reflux disease |
| 124178134 | 12417813 | 10 | Nausea |
| 124178134 | 12417813 | 11 | Vomiting |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124178134 | 12417813 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124178134 | 12417813 | Anaemia | |
| 124178134 | 12417813 | Colitis ischaemic | |
| 124178134 | 12417813 | Haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124178134 | 12417813 | 1 | 20160317 | 0 | ||
| 124178134 | 12417813 | 2 | 20160317 | 0 |